[{"id":"92e4c7fb-dc6e-4dd1-b4cc-48967c24d056","acronym":"CRUKD/17/004","url":"https://clinicaltrials.gov/study/NCT03096054","created_at":"2021-01-18T15:15:19.278Z","updated_at":"2024-07-02T16:35:32.984Z","phase":"Phase 1","brief_title":"A CR-UK Phase I Trial of LY3143921","source_id_and_acronym":"NCT03096054 - CRUKD/17/004","lead_sponsor":"Cancer Research UK","biomarkers":" TP53","pipe":" | ","alterations":" TP53 mutation","tags":["TP53"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TP53 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LY3143921"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 69","initiation":"Initiation: 06/21/2017","start_date":" 06/21/2017","primary_txt":" Primary completion: 02/28/2027","primary_completion_date":" 02/28/2027","study_txt":" Completion: 02/28/2027","study_completion_date":" 02/28/2027","last_update_posted":"2023-10-18"}]